A176 SOFOSBUVIR/VELPATASVIR-BASED REGIMENS ARE ASSOCIATED WITH EXCELLENT EFFICACY AND A SIGNIFICANT IMPROVEMENT OF PATIENTS-REPORTED OUTCOMES ACROSS PATIENT POPULATIONS: FROM NON-CIRRHOTICS TO COMPENSATED CIRRHOTICS TO DECOMPENSATED CIRRHOTICS

AIMS: Our aim was to assess the impact SOF/VEL±ribavirin (RBV) on patient-reported outcomes (PROs) in HCV patients with and without decompensated cirrhosis. METHODS: Four PRO questionnaires (SF-36, CLDQ-HCV, FACIT-F, WPAI:HCV) were collected in 4 phase 3 trials of SOF/VEL (ASTRAL-1,2, 3 and 4). The...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Can Assoc Gastroenterol
Main Authors: Younossi, Z M, Stepanova, M, Feld, J, Zeuzem, S, Sulkowski, M S, Foster, G R, Mangia, A, Charlton, M, O’Leary, J, Curry, M, Nader, F, Henry, L, Hunt, S
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2018
Fag:
Poster Presentations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507918/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.177
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker